Triumeq (ViiV Healthcare Company)
Welcome to the PulseAid listing for the Triumeq drug offered from ViiV Healthcare Company. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | ViiV Healthcare Company |
| NON-PROPRIETARY NAME: | abacavir sulfate, dolutegravir sodium, lamivudine |
| SUBSTANCE NAME: | ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-08-22 |
| END MARKETING DATE: | 0000-00-00 |
Triumeq HUMAN PRESCRIPTION DRUG Details:
| Item Description | Triumeq from ViiV Healthcare Company |
| LABELER NAME: | ViiV Healthcare Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 600; 50; 300(mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2014-08-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 49702-231_ce39c2e0-4718-403d-9b46-5f91e852cd20 |
| PRODUCT NDC: | 49702-231 |
| APPLICATION NUMBER: | NDA205551 |
Other ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE Pharmaceutical Manufacturers / Labelers:
